Oxycodone Trafficking

"Cover of the Quick Facts handout"

Of the 64,124 cases reported to the Commission in fiscal year 2023, 19,066 involved drugs.[1] Of those, 18,939 cases involved drug trafficking;[2] 1.2% of such cases involved oxycodone (down 46.4% since FY 2019). [3]

Click the cover for the PDF handout or learn more below. 

Individual and Offense Characteristics

 

 

  • 76.9% of individuals sentenced for oxycodone trafficking were men.
     
  • 36.8% were Black, 34.1% were White, 15.5% were Hispanic, and 13.6% were Other races. 
     
  • Their average age was 45 years. 
     
  • 98.2% were United States citizens.
     
  • 61.1% had little or no prior criminal history (Criminal History Category I); 1.8% were individuals sentenced under the career offender guideline (§4B1.1). 
     
  • The median base offense level in these cases was 26, corresponding to between 1,990 and 3,483 30-milligram instant release pills of oxycodone. 
     
  • Sentences were increased for:
    • possessing a weapon (16.7%);
    • a leadership or supervisory role in the offense (14.5%).
       
  • Sentences were decreased for:
    • minor or minimal participation in the offense (6.3%);
    • meeting the safety valve criteria in the sentencing guidelines (31.2%).
       
  • The top five districts for oxycodone trafficking offenses were: 
    • District of North Dakota (44); 
    • Southern District of Florida (14); 
    • Southern District of Texas (13); 
    • Southern District of New York (12); 
    • District of New Jersey (12). 

 

 

Punishment

 

  • The average sentence for oxycodone trafficking was 52 months.
     
  • 88.7% were sentenced to prison.
     
  • Oxycodone trafficking does not carry a mandatory minimum penalty. 

 

Sentences Relative to the Guideline Range

 

  • Of the 55.2% of individuals sentenced for oxycodone trafficking under the Guidelines Manual:
    • 38.5% were sentenced within the guideline range.
       
    • 57.4% received a substantial assistance departure. 
      • Their average sentence reduction was 70.3%.
         
    • 0.0% received an Early Disposition Program (EDP) departure.[4]
    • 3.3% received some other downward departure.
      • Their average sentence reduction was 54.6%.
         
  • 44.8% received a variance; of those individuals: 
    • 96.0% received a downward variance.
      • Their average sentence reduction was 54.2%.
         
    • 4.0% received an upward variance.
      • Their average sentence increase was 100.2%.

 

 

 

 

  • The average guideline minimum increased and average sentence imposed has fluctuated over the past five years. 
    • The average guideline minimum increased from 68 months in fiscal year 2019 to 90 months in fiscal year 2023. 
       
    • The average sentence imposed increased and decreased throughout the fiscal years. The average sentence was 45 months in fiscal year 2019 and 52 months in fiscal year 2023. 

 

 

 

 

[1] Drug offenses include cases where individuals were sentenced under USSG Chapter Two, Part D (Drugs). There were 234 individuals sentenced for oxycodone offenses sentenced under USSG Chapter Two, Part D (Drugs) in FY 2023.

[2] Individuals sentenced for drug trafficking were sentenced under USSG §§2D1.1 (Drug Trafficking), 2D1.2 (Protected Locations), 2D1.5 (Continuing Criminal Enterprise), 2D1.6 (Use of a Communication Facility), 2D1.8 (Rent/Manage Drug Establishment), 2D1.10 (Endangering Human Life), or 2D1.14 (Narco-Terrorism).

[3] Cases with incomplete sentencing information were excluded from the analysis.

[4] “Early Disposition Program (or EDP) departures” are departures where the government sought a sentence below the guideline range because the defendant participated in the government’s Early Disposition Program, through which cases are resolved in an expedited manner. See USSG §5K3.1.

SOURCE: United States Sentencing Commission, FY 2019 through FY 2023 Datafiles, USSCFY19-USSCFY23.